Canada Life’s Health Catalyst HCAT Stock Holding History

Canada Life’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,158	Closed	-$317K	–	2114
2024 Q1	$317K	Sell	42,158 -2,390	-5%	-$21.8K	﹤0.01%	1767
2023 Q4	$409K	Hold	44,548	–	–	﹤0.01%	1743
2023 Q3	$451K	Buy	44,548 +5,053	+13%	+$60.3K	﹤0.01%	1704
2023 Q2	$497K	Buy	39,495 +5,379	+16%	+$64.1K	﹤0.01%	1686
2023 Q1	$399K	Hold	34,116	–	–	﹤0.01%	1751
2022 Q4	$364K	Buy	34,116 +16,288	+91%	+$157K	﹤0.01%	1780
2022 Q3	$173K	Buy	17,828 +15,754	+760%	+$209K	﹤0.01%	1898
2022 Q2	$30K	Hold	2,074	–	–	﹤0.01%	2179
2022 Q1	$58K	Hold	2,074	–	–	﹤0.01%	2119
2021 Q4	$82K	Hold	2,074	–	–	﹤0.01%	2051
2021 Q3	$104K	Hold	2,074	–	–	﹤0.01%	2045
2021 Q2	$115K	Buy	2,074 +876	+73%	+$46.7K	﹤0.01%	2051
2021 Q1	$56K	Buy	1,198 +583	+95%	+$28.2K	﹤0.01%	2260
2020 Q4	$27K	Hold	615	–	–	﹤0.01%	2485
2020 Q3	$22K	Hold	615	–	–	﹤0.01%	2421
2020 Q2	$18K	Hold	615	–	–	﹤0.01%	2510
2020 Q1	$16K	Hold	615	–	–	﹤0.01%	2423
2019 Q4	$21K	Buy	+615	New	+$20.4K	﹤0.01%	2485

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Canada Life's HCAT Position: Q2 2024 in Review

Canada Life sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 42,158 shares — an estimated $317K sold.

Canada Life first reported a position in HCAT in Q4 2019 and held it in 18 quarters. The position peaked at $497K in Q2 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

Canada Life reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
Canada Life sold 42,158 Health Catalyst shares in Q2 2024, an estimated $317K.
Canada Life first reported a position in Health Catalyst in Q4 2019 and held it in 18 quarters.
Canada Life's Health Catalyst position peaked at $497K in Q2 2023.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Canada Life's 13F filing for Q2 2024, filed 12 Aug 2024.